$1.52 Million is the total value of Cormorant Asset Management, LP's 72 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 34.2% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
RXDX | Sell | PROMETHEUS BIOSCIENCES INC | $177,615 | -22.7% | 1,655,000 | -20.8% | 11.70% | -24.0% |
Buy | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $147,422 | +131.5% | 6,892,101 | +13.6% | 9.71% | +127.9% | |
BMEA | Buy | BIOMEA FUSION INC | $110,733 | +314.3% | 3,570,872 | +12.6% | 7.29% | +307.7% |
APLS | Sell | APELLIS PHARMACEUTICALS INC | $89,706 | +10.0% | 1,360,000 | -13.8% | 5.91% | +8.3% |
AMAM | Buy | AMBRX BIOPHARMA INCsponsored ads | $75,820 | +1329.5% | 8,500,000 | +263.8% | 4.99% | +1306.5% |
BBIO | Buy | BRIDGEBIO PHARMA INC | $75,562 | +624.3% | 4,557,414 | +232.9% | 4.98% | +612.9% |
Sell | ARCELLX INC | $49,296 | -23.3% | 1,600,000 | -22.9% | 3.25% | -24.5% | |
ETNB | Buy | 89BIO INC | $42,644 | +31.4% | 2,800,000 | +9.8% | 2.81% | +29.3% |
New | ENLIVEN THERAPEUTICS INC | $42,401 | – | 1,936,133 | +100.0% | 2.79% | – | |
RNA | Sell | AVIDITY BIOSCIENCES INC | $40,096 | -34.6% | 2,612,115 | -5.4% | 2.64% | -35.6% |
PTGX | New | PROTAGONIST THERAPEUTICS INC | $39,100 | – | 1,700,000 | +100.0% | 2.58% | – |
PLRX | Buy | PLIANT THERAPEUTICS INC | $38,410 | +153.8% | 1,444,000 | +84.5% | 2.53% | +150.0% |
ERASCA INC | $32,548 | -30.2% | 10,813,246 | 0.0% | 2.14% | -31.3% | ||
AVTE | Sell | AEROVATE THERAPEUTICS INC | $31,499 | -45.1% | 1,561,696 | -20.2% | 2.07% | -45.9% |
DSGN | DESIGN THERAPEUTICS INC | $29,716 | -43.8% | 5,150,000 | 0.0% | 1.96% | -44.7% | |
RAIN | RAIN ONCOLOGY INC | $26,033 | +9.2% | 2,978,660 | 0.0% | 1.71% | +7.5% | |
Buy | IMMUNEERING CORP | $23,170 | +109.0% | 2,386,181 | +4.4% | 1.53% | +105.7% | |
GLUE | MONTE ROSA THERAPEUTICS INC | $22,542 | +2.4% | 2,893,717 | 0.0% | 1.48% | +0.7% | |
VRDN | Sell | VIRIDIAN THERAPEUTICS INC | $21,624 | -32.7% | 850,000 | -22.7% | 1.42% | -33.8% |
VECT | VECTIVBIO HLDG AG | $21,587 | -1.8% | 2,536,617 | 0.0% | 1.42% | -3.3% | |
EWTX | EDGEWISE THERAPEUTICS INC | $19,656 | -25.4% | 2,946,887 | 0.0% | 1.29% | -26.6% | |
AXSM | Sell | AXSOME THERAPEUTICS INC | $18,504 | -26.2% | 300,000 | -7.7% | 1.22% | -27.3% |
TARS | Sell | TARSUS PHARMACEUTICALS INC | $17,867 | -29.8% | 1,421,422 | -18.1% | 1.18% | -30.9% |
AXNX | AXONICS INC | $17,581 | -12.7% | 322,240 | 0.0% | 1.16% | -14.1% | |
VKTX | Buy | VIKING THERAPEUTICS INC | $17,483 | +165.7% | 1,050,000 | +50.0% | 1.15% | +161.6% |
TANGO THERAPEUTICS INC | $16,262 | -45.5% | 4,116,949 | 0.0% | 1.07% | -46.4% | ||
SRPT | Sell | SAREPTA THERAPEUTICS INC | $15,161 | -41.5% | 110,000 | -45.0% | 1.00% | -42.4% |
CABA | Sell | CABALETTA BIO INC | $15,066 | -17.4% | 1,821,739 | -7.6% | 0.99% | -18.7% |
RCKT | ROCKET PHARMACEUTICALS INC | $14,878 | -12.5% | 868,550 | 0.0% | 0.98% | -13.8% | |
KRTX | Sell | KARUNA THERAPEUTICS INC | $14,531 | -32.8% | 80,000 | -27.3% | 0.96% | -33.8% |
New | STRUCTURE THERAPEUTICS INCsponsored ads | $13,712 | – | 576,373 | +100.0% | 0.90% | – | |
Sell | ASTRIA THERAPEUTICS INC | $13,300 | -45.9% | 1,000,000 | -39.4% | 0.88% | -46.7% | |
MORF | New | MORPHIC HLDG INC | $12,233 | – | 325,000 | +100.0% | 0.81% | – |
RAPT | New | RAPT THERAPEUTICS INC | $11,928 | – | 650,000 | +100.0% | 0.79% | – |
CBAY | New | CYMABAY THERAPEUTICS INC | $11,087 | – | 1,271,429 | +100.0% | 0.73% | – |
OLMA | Buy | OLEMA PHARMACEUTICALS INC | $10,695 | +109.7% | 3,082,000 | +48.0% | 0.70% | +106.5% |
CYTK | CYTOKINETICS INC | $10,416 | -23.2% | 296,000 | 0.0% | 0.69% | -24.4% | |
PCVX | Sell | VAXCYTE INC | $10,307 | -33.9% | 275,000 | -15.4% | 0.68% | -34.9% |
LBPH | Buy | LONGBOARD PHARMACEUTICALS IN | $9,436 | +36.6% | 2,353,141 | +11.1% | 0.62% | +34.4% |
STOK | STOKE THERAPEUTICS INC | $9,061 | -9.8% | 1,087,807 | 0.0% | 0.60% | -11.2% | |
PRIME MEDICINE INC | $9,033 | -33.8% | 734,350 | 0.0% | 0.60% | -34.8% | ||
New | LIANBIOsponsored ads | $8,330 | – | 4,250,000 | +100.0% | 0.55% | – | |
COGT | Sell | COGENT BIOSCIENCES INC | $7,553 | -27.4% | 700,000 | -22.2% | 0.50% | -28.6% |
PHVS | PHARVARIS N V | $6,577 | -28.4% | 816,460 | 0.0% | 0.43% | -29.6% | |
VIGIL NEUROSCIENCE INC | $6,038 | -21.7% | 616,786 | 0.0% | 0.40% | -22.9% | ||
AVIR | ATEA PHARMACEUTICALS INC | $5,183 | -30.4% | 1,547,181 | 0.0% | 0.34% | -31.5% | |
VERV | VERVE THERAPEUTICS INC | $5,047 | -25.5% | 350,000 | 0.0% | 0.33% | -26.7% | |
IDYA | IDEAYA BIOSCIENCES INC | $4,806 | -24.4% | 350,000 | 0.0% | 0.32% | -25.6% | |
ANNX | New | ANNEXON INC | $4,813 | – | 1,250,000 | +100.0% | 0.32% | – |
GHRS | GH RESEARCH PLCordinary shares | $4,738 | -17.8% | 593,043 | 0.0% | 0.31% | -19.2% | |
GREENLIGHT BIOSCIENCS HLDS P | $3,973 | -63.4% | 9,188,659 | 0.0% | 0.26% | -63.9% | ||
ICOSAVAX INC | $3,734 | -27.0% | 643,825 | 0.0% | 0.25% | -28.1% | ||
ELEV | ELEVATION ONCOLOGY INC | $3,709 | +100.1% | 1,952,032 | 0.0% | 0.24% | +96.8% | |
BCAB | Sell | BIOATLA INC | $3,165 | -89.6% | 1,181,115 | -67.9% | 0.21% | -89.8% |
PSTX | Sell | POSEIDA THERAPEUTICS INC | $3,080 | -49.5% | 1,000,000 | -13.0% | 0.20% | -50.2% |
FULC | New | FULCRUM THERAPEUTICS INC | $3,082 | – | 1,081,490 | +100.0% | 0.20% | – |
ELDN | ELEDON PHARMACEUTICALS INC | $2,874 | +3.5% | 1,217,882 | 0.0% | 0.19% | +1.6% | |
ALXO | ALX ONCOLOGY HLDGS INC | $2,767 | -59.9% | 612,079 | 0.0% | 0.18% | -60.6% | |
CNTA | CENTESSA PHARMACEUTICALS PLCsponsored ads | $2,162 | +24.2% | 561,600 | 0.0% | 0.14% | +22.4% | |
GLTO | GALECTO INC | $2,030 | +73.1% | 1,020,238 | 0.0% | 0.13% | +71.8% | |
TALS | TALARIS THERAPEUTICS INC | $1,693 | +84.2% | 900,649 | 0.0% | 0.11% | +82.0% | |
XFOR | X4 PHARMACEUTICALS INC | $1,417 | -12.4% | 1,628,980 | 0.0% | 0.09% | -13.9% | |
BIOHAVEN LTD | $1,120 | -1.6% | 81,963 | 0.0% | 0.07% | -2.6% | ||
Sell | PYXIS ONCOLOGY INC | $1,093 | +22.0% | 272,537 | -59.3% | 0.07% | +20.0% | |
AUTL | AUTOLUS THERAPEUTICS PLCspon ads | $722 | -3.1% | 392,167 | 0.0% | 0.05% | -4.0% | |
EYPT | New | EYEPOINT PHARMACEUTICALS INC | $662 | – | 225,065 | +100.0% | 0.04% | – |
LPTX | New | LEAP THERAPEUTICS INC | $504 | – | 1,481,511 | +100.0% | 0.03% | – |
GRPH | GRAPHITE BIO INC | $489 | -26.1% | 199,547 | 0.0% | 0.03% | -27.3% | |
CMMB | CHEMOMAB THERAPEUTICS LTDsponsored ads | $458 | -50.3% | 288,169 | 0.0% | 0.03% | -51.6% | |
HARP | HARPOON THERAPEUTICS INC | $402 | +2.6% | 540,600 | 0.0% | 0.03% | 0.0% | |
BCEL | ATRECA INC | $364 | +42.7% | 319,057 | 0.0% | 0.02% | +41.2% | |
New | ORCHARD THERAPEUTICS PLCspon ads new | $138 | – | 25,664 | +100.0% | 0.01% | – | |
ORTX | Exit | ORCHARD THERAPEUTICS PLCspon ads | $0 | – | -256,649 | -100.0% | -0.01% | – |
YMAB | Exit | Y-MABS THERAPEUTICS INC | $0 | – | -150,000 | -100.0% | -0.05% | – |
KROS | Exit | KEROS THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -0.32% | – |
ACET | Exit | ADICET BIO INC | $0 | – | -600,000 | -100.0% | -0.36% | – |
ASND | Exit | ASCENDIS PHARMA A/Ssponsored adr | $0 | – | -50,000 | -100.0% | -0.41% | – |
ALT | Exit | ALTIMMUNE INCcall | $0 | – | -400,000 | -100.0% | -0.44% | – |
IMVT | Exit | IMMUNOVANT INC | $0 | – | -400,000 | -100.0% | -0.48% | – |
ARQT | Exit | ARCUTIS BIOTHERAPEUTICS INC | $0 | – | -650,000 | -100.0% | -0.64% | – |
MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -400,000 | -100.0% | -1.21% | – |
Exit | AMYLYX PHARMACEUTICALS INC | $0 | – | -550,000 | -100.0% | -1.36% | – | |
Exit | VENTYX BIOSCIENCES INC | $0 | – | -1,080,643 | -100.0% | -2.37% | – | |
ALT | Exit | ALTIMMUNE INC | $0 | – | -2,600,000 | -100.0% | -2.86% | – |
RVMD | Exit | REVOLUTION MEDICINES INC | $0 | – | -1,895,066 | -100.0% | -3.02% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
QUOTIENT LTD | 30 | Q3 2021 | 4.3% |
ASCENDIS PHARMA A/S | 30 | Q4 2022 | 4.8% |
MINERVA NEUROSCIENCES INC | 29 | Q3 2021 | 4.4% |
ACCELERON PHARMA INC | 28 | Q2 2021 | 3.4% |
OMEROS CORP | 27 | Q3 2021 | 6.5% |
MIRATI THERAPEUTICS INC | 25 | Q4 2022 | 7.6% |
BLUEPRINT MEDICINES CORP | 25 | Q3 2021 | 3.6% |
APELLIS PHARMACEUTICALS INC | 24 | Q3 2023 | 8.6% |
NEUROCRINE BIOSCIENCES INC | 24 | Q1 2020 | 4.6% |
ROCKET PHARMACEUTICALS, INC | 23 | Q3 2023 | 2.4% |
View Cormorant Asset Management, LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Immuneering Corp | April 24, 2023 | 1,996,779 | - |
Ambrx Biopharma Inc. | March 13, 2023 | 42,771,365 | - |
Altimmune, Inc. | February 14, 2023 | 2,600,000 | - |
Arcellx, Inc. | February 14, 2023 | 2,075,000 | - |
BioAtla, Inc. | February 14, 2023 | 2,499,250 | - |
Eledon Pharmaceuticals, Inc. | February 14, 2023 | 1,391,663 | - |
GreenLight Biosciences Holdings, PBC | February 14, 2023 | 4,751,020 | - |
Prometheus Biosciences, Inc. | February 14, 2023 | 700,000 | - |
Tango Therapeutics, Inc. | February 14, 2023 | 1,000,000 | - |
VectivBio Holding AG | February 14, 2023 | 1,515,087 | - |
View Cormorant Asset Management, LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G | 2024-03-21 |
4 | 2024-03-18 |
SC 13G/A | 2024-03-18 |
4 | 2024-03-11 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
View Cormorant Asset Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.